Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
IGC Pharma Inc (AMEX: IGC) closed the day trading at $0.31 up 4.87% from the previous closing price of $0.30. In other words, the price has increased by $4.87 from its previous closing price. On the day, 0.57 million shares were traded.
Ratios:
For a better understanding of IGC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.59 and its Current Ratio is at 1.15. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 25 ’24 when Moran James P bought 588,235 shares for $0.34 per share. The transaction valued at 200,000 led to the insider holds 942,402 shares of the business.
PRINS RICHARD K bought 200,000 shares of IGC for $78,200 on Aug 12 ’24.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 20.09 while its Price-to-Book (P/B) ratio in mrq is 3.90.
Stock Price History:
Over the past 52 weeks, IGC has reached a high of $0.55, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is 4.65%, while the 200-Day Moving Average is calculated to be -7.73%.
Shares Statistics:
A total of 78.20M shares are outstanding, with a floating share count of 54.38M. Insiders hold about 31.76% of the company’s shares, while institutions hold 3.59% stake in the company.
